-
Investor Relations
- Corporate Governance
- Investor Presentations
- LIBOR Transition
- Compliance and AML
- Sustainability
- Financial Information
- Shareholders Toolkit
- FAQs
- Investors’ Queries
-
-
Accounts
- Al Hayrat Account
- Current Account
- Fixed Deposits Account
- Money Maker Account
- Salary Transfer Account
- Starmaker Account
- Super Saver Account
Al Wajaha
- Overview
BBK Lite
- Overview
NRI
- NRI Services
Debit Cards
- Classic
- Gold
- Signature
- Infinite
Self-service Banking
- ATM
- Deposit Machines
- Interactive Teller Machines
- Bank Certificates Issuance Machines
- Debit Card Issuance Machines
Foreign Exchange
- Remittance
- American Express
-
Insurance
- Home Secura
- Motor Secura
- Travel Secura
Investment
- Bonds
- IPO
- Mutual Funds
- Real Estate Investment
-
Branches and Self-Service
- Branches
- ATM
- Deposit Machines
- Debit Card Issuance Machines
- Corporate Deposit Machines
- Interactive Teller Machines
- Bank Certificates Issuance Machines
- BBK Virtual
Contactless Payments
- Apple Pay
- Samsung Wallet
- Google Pay
- Garmin Pay
- Fitbit Pay
More Ways to Bank
- New Mobile app & Online Banking
- eStatements
- BBK BanKey
- Corporate Deposit Card
- Debit Card
- Telebanking
- Open Banking
- AFAQ Payment System
Sign Language
- Sign Language Directory
-
-
-
Accounts
- Business Current Account
- Business Fixed Deposit Account
Cash Management
- Bankey eBanking
- Payroll Services
- Deposit Machines
- POS Credimax
- Remittance
-
Working Capital Finance
- Overdraft
- Cheque discounting
- Short Term Loans
Long Term Finance
- Project Finance
- Assets Finance
- Real estate Finance
-
Corporate Banking
- Government Affairs
- Real Estate, Services and Trading
- Contracting, Building Material, and Manufacturing
International Banking
- Overview
- Services
- NRI
- Offshore Branches
- Representative offices
Enterprise Banking
- Overview
-
-
-
-
FINANCIAL NEWS
Hekma Pharmaceuticals revenue up 41 percent in H1
21 Aug 2014
(MENAFN) Hikma Pharmaceuticals announced posting a 44 percent increase in its profit in the January-June period due to a strong performance in its injectable business in the US, The Peninsula Qatar reported.
The Jordanian drug maker’s revenue increased 41 percent, hitting USD346 million, while operating margins in the business was up 41 percent compared to 28.5 percent in the same period last year.
“This reflects exceptionally strong sales from certain market opportunities in the U.S., a focus on higher-value products and tight control of overhead costs across our manufacturing facilities,” the company said.
More News
17 Nov 2024
BBK and Asia Jewellers announce exclusive offers to its customers at Jewellery Arabia 2024
12 Nov 2024
BBK partners with Durrat Al Bahrain to offer exclusive financing for Jawhart Al Marjan
05 Nov 2024
As part of its digital transformation journey, BBK adds Google Wallet to its range of digital wallets
This website uses cookies to ensure you get the best experience and by clicking “I Accept” below, you consent to the use of cookies. Learn more